
Unilife Medical Solutions Limited
News
Signing of an exclusive agreement with one of the world's largest pharmaceutical groups in December 2006 to develop the UnitractTM Prefilled Syringe for one of its major drug products. After a successful review of product specifications in July 2007, both parties are now finalizing an extension of this agreement.
Unilife Medical Solutions Limited ("Unilife" or the "Company") (ASX: UNI) announces the variation of the purchase price terms of the acquisition agreement ('Agreement') pursuant to which the Company acquired all of the issued shares in Integrated BioSciences Inc. ("IBS") in January 2007.
Unilife Medical Solutions Limited ("Unilife") (ASX: UNI) is pleased to announce the successful testing of its fully automated assembly line developed for the manufacture of the Unitract(tm) range of 1mL syringes at its US facility, Integrated BioSciences Inc ("IBS")
Unilife Medical Solutions Limited (ASX: UNI) - Unilife signs agreement with Multinational Pharmaceutical Group - Mr Alan Shortall, CEO; Boardroomradio is pleased to announce that Unilife Medical Solutions Limited (ASX: UNI) has published an audio file.
1,976 COMPANY PROFILE VIEWS
- This Page Viewed: (Last 7 Days: 3) (Last 30 Days: 26) (Since Published: 1976)